Informations générales (source: ClinicalTrials.gov)

NCT02206672 Statut inconnu
EFFECTS OF THE MICRO REINJECTION OF AUTOLOGOUS ADIPOSE TISSUE IN THE FACE OF PATIENTS WITH SYSTEMIC SCLEROSIS (FACE)
Interventional
  • Sclérodermie systémique
  • Sclérose
  • Sclérodermie diffuse
N/A
Assistance Publique Hopitaux De Marseille (Voir sur ClinicalTrials)
juillet 2014
novembre 2015
29 juin 2024
This prospective single-center study evaluates a current care procedure. It includes 14 patients diagnosed with SSc according to the ACR/EULAR criteria or the Leroy & Medsger criteria of the disease. Patients are enrolled if they wish for a therapeutic care of their face, have a Mouth Handicap in Systemic Sclerosis (MHISS) score greater than 20 (scale 0-48), a modified Rodnan skin score upper or equal to 1 on the face (scale 0-3), and a mouth opening less than 55 millimeters. They should not have anticoagulant, anti-platelets aggregation medication or a daily steroid dose upper 20mg per day. Their BMI should exceed 17. Micro fat grafting is a minimally invasive and usual procedure performed under local anesthesia. Fat tissue is harvested (around 50 milliliters) using a 14 gauge or 2 mm diameter cannula from areas around the knees, the abdomen or the hips under a gentle aspiration. Lipoaspirated fat is then filtrated by the PureGraft system that offers a sterile, closed, single-use system, leading to a fast, consistent and controlled preparation. Then, 10 to 25 milliliters of this purified fat product is transferred through a 21 gauge or 0.8 mm diameter cannula in two or four points of the face, with the entry points located around the mouth.

Etablissements

Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
Assistance Publique Hopitaux de Marseille - 13354 - Marseille - France BRIGITTE GRANEL En recrutement Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- Patients older than 18 or younger than 80 years.

- Suffering from systemic scleroderma.

- Patient follow-AP-HM.

- Score of 20 or greater MHISS.

- Score Rodnan level greater than or equal to one face.

- Mouth opening (inter-incisor distance) <5.5 cm

- Wishing to receive surgery at the face.



- Less than 18 or greater than 80 age.

- Decaying history of abdominal surgery.

- Body mass index lower than 18.

- Coagulation disorders.

- Allergy to Xylocaine.

- Greater than 20mg / d steroids.

- Severe infection.

- Inmates.

- Pregnant women.

- Adults protected by law (under guardianship and trusteeship).

- No affiliation to a social security scheme.